Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Bellerophon Therapeutics, Inc. (BLPH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K/A
Total revenues   [+]0.00.00.00.00.00.00.033.4
            Revenue growth        -100.0% 
Cost of goods sold  0.00.00.00.00.00.00.031.7
Gross profit  0.00.00.00.00.00.00.01.7
            Gross margin         5.0%
Selling, general and administrative   [+]6.07.18.46.47.66.77.114.9
Research and development  16.413.017.911.020.317.916.7 
Other operating expenses         33.4
EBITDA   [+]-22.3-20.1-26.1-17.1-27.5-24.2-23.4-46.2
            EBITDA margin         -138.4%
Depreciation and amortization  0.10.10.10.30.40.40.40.4
EBIT   [+]-22.4-20.2-26.3-17.5-27.9-24.6-23.8-46.6
            EBIT margin         -139.6%
Interest income       0.20.1 
Other income (expense), net   [+]0.10.6-0.62.425.3-30.4-0.60.1
Pre-tax income  -22.2-19.6-26.9-15.1-2.6-54.8-24.3-46.5
Income taxes  -2.4-1.8-2.1-1.8-5.40.0-0.40.0
            Tax rate  10.9%9.2%7.9%12.0%207.2%0.0%1.8%0.0%
Net income  -19.8-17.8-24.7-13.32.8-54.8-23.8-46.5
            Net margin         -139.2%
   
Basic EPS   [+]($2.08)($1.87)($3.17)($2.95)$0.73($21.11)($1.58)($3.79)
Diluted EPS   [+]($2.08)($1.87)($3.17)($2.95)$0.65($21.11)($1.58)($3.79)
   
Shares outstanding (basic)   [+]9.69.57.84.53.82.615.112.3
Shares outstanding (diluted)   [+]9.69.57.84.54.32.615.112.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy